| scholarly article | Q13442814 |
| P356 | DOI | 10.3945/AJCN.114.086413 |
| P8608 | Fatcat ID | release_k4utepuqeveflfqxv7s26gmsy4 |
| P932 | PMC publication ID | 4196486 |
| P698 | PubMed publication ID | 25332334 |
| P5875 | ResearchGate publication ID | 267273886 |
| P50 | author | Nicholas J. Wareham | Q56936055 |
| Kay-Tee Khaw | Q28356290 | ||
| Robert N. Luben | Q30506463 | ||
| P2860 | cites work | Vitamin D for cancer prevention: global perspective | Q37518120 |
| Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies | Q37769845 | ||
| Vitamin D: epidemiology of cardiovascular risks and events | Q37923118 | ||
| Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies | Q37985498 | ||
| Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies | Q38004818 | ||
| Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). | Q38074186 | ||
| Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study | Q39535662 | ||
| Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. | Q41196304 | ||
| Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study | Q42442679 | ||
| Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden | Q43120692 | ||
| Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). | Q43485561 | ||
| Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study | Q43851907 | ||
| Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study | Q43955846 | ||
| Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. | Q46585248 | ||
| Vitamin D and fracture prevention | Q47867092 | ||
| Area deprivation predicts lung function independently of education and social class | Q47946738 | ||
| EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer | Q57202839 | ||
| Determining vitamin D status: a comparison between commercially available assays | Q21136316 | ||
| Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials | Q22306552 | ||
| Vitamin D supplementation for prevention of mortality in adults | Q24201160 | ||
| Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey | Q24598040 | ||
| Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials | Q24634794 | ||
| Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe | Q24646707 | ||
| Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition | Q28204672 | ||
| A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability | Q28660409 | ||
| Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study | Q28749202 | ||
| Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials | Q33298477 | ||
| Plasma vitamin D and mortality in older men: a community-based prospective cohort study | Q33447581 | ||
| The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum | Q33452232 | ||
| The case against ergocalciferol (vitamin D2) as a vitamin supplement | Q33845087 | ||
| Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial | Q34180229 | ||
| A pooled analysis of vitamin D dose requirements for fracture prevention | Q34286007 | ||
| Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. | Q34315268 | ||
| Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence | Q34336083 | ||
| Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis | Q34371127 | ||
| Vitamin D status and ill health: a systematic review | Q34409755 | ||
| Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies | Q34413128 | ||
| Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study | Q34469871 | ||
| Vitamin D and subsequent all-age and premature mortality: a systematic review. | Q34863028 | ||
| The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial | Q36111925 | ||
| Vitamin D effects on lung immunity and respiratory diseases | Q36574418 | ||
| Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study | Q36784395 | ||
| Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis | Q36840607 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone fracture | Q68833 |
| cardiovascular disease | Q389735 | ||
| respiratory disease | Q3286546 | ||
| P304 | page(s) | 1361-1370 | |
| P577 | publication date | 2014-09-17 | |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study | |
| P478 | volume | 100 |
| Q90334243 | 25-Hydroxyvitamin D and Total Cancer Incidence and Mortality: A Meta-Analysis of Prospective Cohort Studies |
| Q92850174 | A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan |
| Q91436927 | Airway obstruction, serum vitamin D and mortality in a 33-year follow-up study |
| Q57479955 | Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival |
| Q38810392 | Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial |
| Q47138400 | Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D). |
| Q36165282 | Fracture Risk in Relation to Serum 25-Hydroxyvitamin D and Physical Activity: Results from the EPIC-Norfolk Cohort Study |
| Q35961214 | Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men |
| Q42406333 | Long follow-up time and different sensitivities of cancer types may have obscured the effect of 25-hydroxyvitamin D on cancer incidence and mortality rates |
| Q37639407 | Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care |
| Q35672634 | Patients with Active Acromegaly are at High Risk of 25(OH)D Deficiency |
| Q64126066 | Plasma 25-Hydroxyvitamin D Concentrations Are Inversely Associated with All-Cause Mortality among a Prospective Cohort of Chinese Adults Aged ≥80 Years |
| Q55502315 | Prevalence of vitamin D insufficiency among children in southern china: A cross-sectional survey. |
| Q37635465 | Relationship between outdoor temperature and cardiovascular disease risk factors in older people |
| Q42406329 | Reply to WB Grant |
| Q38935458 | Serum 25-Hydroxyvitamin D associated with indicators of body fat and insulin resistance in prepubertal chilean children. |
| Q47920280 | Serum 25-hydroxyvitamin D as a predictor of mortality and cardiovascular events: A 20-year study of a community-based cohort |
| Q90395873 | Serum level vitamin D and parathyroid hormone, and mortality, with or without chronic kidney disease |
| Q64902068 | Severity of Vitamin D Deficiency Predicts Mortality in Ischemic Stroke Patients. |
| Q60921467 | Tai chi for treating osteopenia and primary osteoporosis: a meta-analysis and trial sequential analysis |
| Q39248319 | The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies |
| Q47845509 | Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study. |
| Q34517376 | VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,0 |
| Q62568003 | Vitamin D Status and Mortality: A Systematic Review of Observational Studies |
| Q38795645 | Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges |
| Q58597567 | Vitamin D and bisphosphonates therapies for osteoporosis are associated with different risks of atrial fibrillation in women: A nationwide population-based analysis |
| Q47855511 | Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians |
| Q90568488 | Vitamin D as a Biomarker of Ill Health among the Over-50s: A Systematic Review of Cohort Studies |
| Q26777798 | Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: Still a myth or a fact that needs exploration? |
| Q90095771 | Vitamin D status and cardiometabolic risk markers in young Swedish children: a double-blind randomized clinical trial comparing different doses of vitamin D supplements |
Search more.